Loading...
XJPX
2871
Market cap3.29bUSD
Oct 09, Last price  
2,099.50JPY
1D
1.40%
1Q
-1.62%
Jan 2017
73.51%
Name

Nichirei Corp

Chart & performance

D1W1MN
XJPX:2871 chart
P/E
19.25
P/S
0.73
EPS
109.06
Div yield, %
2.34%
Shrs. gr., 5y
-1.22%
Rev. gr., 5y
4.57%
Revenues
716.14b
+2.00%
457,655,000,000463,591,000,000474,515,000,000438,111,000,000437,808,000,000454,931,000,000470,126,000,000511,189,000,000545,266,000,000535,351,000,000539,657,000,000568,032,000,000580,141,000,000584,858,000,000572,757,000,000602,696,000,000662,204,000,000680,091,000,000702,080,000,000716,144,000,000
Net income
27.33b
+10.52%
10,845,000,0009,623,000,0006,020,000,0009,064,000,0004,044,000,0007,904,000,0009,823,000,0008,898,000,0009,701,000,00013,471,000,00018,752,000,00019,097,000,00019,944,000,00019,610,000,00021,212,000,00023,382,000,00021,569,000,00024,495,000,00024,731,000,00027,332,000,000
CFO
48.75b
-8.36%
22,431,000,00020,290,000,00015,282,000,00033,345,000,00017,274,000,00019,915,000,00023,525,000,00011,073,000,00027,803,000,00037,032,000,00040,828,000,00029,859,000,00031,311,000,00039,441,000,00045,453,000,00034,660,000,00037,865,000,00062,442,000,00053,194,000,00048,746,000,000
Dividend
Dec 30, 202625 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nichirei Corporation, a Tokyo-based Japanese company, operates a diverse business portfolio encompassing processed foods, marine products, meat and poultry, logistics, real estate, and biosciences. Its food offerings include frozen meals, acerola-based goods, packaged ice, processed agricultural items, wellness foods, and retort-pouch preparations. The firm's logistics division delivers cold storage warehousing, transportation, and delivery services, along with strategic logistics consulting, and is also involved in the production and sale of ice. Its real estate activities involve leasing and managing office buildings and parking facilities, marketing residential land, and offering construction and planning expertise. Furthermore, Nichirei's biosciences segment focuses on cell biotechnology and the development of functional materials. Founded in 1942, Nichirei was initially established as Nippon Reizo Co. Ltd. before rebranding as Nichirei Corporation in February 1985.

Key people

Kenji Suzuki
Senior Executive Officer, Chief Financial Officer, Chief Director of Corporate Management, Director · since 2025
Masahiko Takenaga
Senior Executive Officer, Chief Operating Officer, Director · since 2026
Hideo Yokoi
Senior Executive Officer, President of Subsidiary · since 2023
Emi Kataoka
Executive Officer, Director of Diversity Promotion · since 2024
Takuji Okugawa
Executive Officer, Director of Quality Assurance · since 2023
Jouji Sakaguchi
Executive Officer, Director of Information Strategy · since 2023
Kenya Okushi
Chairman of the Board, Representative Director · since 2026
Kazunori Shimamoto
Senior Executive Officer, President of Subsidiary, Director · since 2024
Yuichi Takaku
Senior Executive Officer, Chief Director of Strategy, Director of Business Planning, Director · since 2025
Wataru Tanabe
Senior Executive Officer, President of Subsidiary, Director · since 2023
Independent Director · since 2022
Kenji Hamashima
Independent Director · since 2022
Independent Director · since 2021
Independent Director · since 2024
Independent Director · since 2024
IPO date
May 16, 1949
Employees
15,766
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
中央区築地6丁目19番20号
東京都, 13 104-8402
JP
Other language
Nichirei Corporation

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT